Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN000869 | Fluroxypyr | 0.84 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 2-Pyridylthioamide | 0.84 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Phosphonoacetate | 0.84 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 2,4-Dichloro-3-oxoadipate | 0.84 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 6-Thioxanthine 5'-monophosphate | 0.91 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Distemonanthin | 0.91 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Distemonanthin - 0.9142415 | 0.91 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 5,7,4'-Trihydroxyflavanone 7-sulfate | 0.92 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Carboxytolbutamide | 0.92 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Sulfamethizole | 0.92 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Valdecoxib | 0.92 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine | 0.92 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Proanthocyanidin A2 | 0.93 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Mahuannin D | 0.94 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | edetate | 0.94 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | N(6)-Methyllysine | 0.94 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 2'-Deoxyuridine | 0.94 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Gluconic acid | 0.94 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | floxuridine | 0.95 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 7-Hydroxymethotrexate | 0.95 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 4-Methylumbelliferyl ?-D-glucuronide | 0.96 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 5-O-Feruloylquinic acid | 0.96 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Sulfinpyrazone sulfone | 0.96 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Millettosin | 0.97 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Fagomine | 1.01 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Quinic acid | 1.01 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Creatinine | 1.05 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 5-Dehydro-4-deoxy-D-glucarate | 1.33 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Uric acid | 1.39 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | AMCC | 1.41 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Quinol sulfate | 3.8 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Tris(2-chloroethyl)phosphate | 3.98 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Tryptophan | 3.98 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 3-keto-n-caproic acid | 3.99 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Phenol | 4.13 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 4-Hydroxybenzenesulfonic acid | 4.13 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | TG(22:0/22:0/22:0) | 4.13 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 2-Aminoadenosine | 4.21 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | AFMK | 4.71 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 5,8-Dihydroxy-3,4-dihydrocarbostyril | 4.74 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | p-cresol | 5.15 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 4-Sulfobenzyl alcohol | 5.15 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Dolichol-16 | 5.15 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Lys His Cys | 5.63 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Phenyl beta-D-glucopyranoside | 5.79 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Steryl sulfate | 6.15 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 3b,16a-Dihydroxyandrostenone sulfate | 6.29 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 17-?, 21-dihydroxy-11,20-dioxo-5-?-pregnan-3-?-yl-?-d-glucuronide | 6.43 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 5?-Androstan-3?-ol-17-one sulfate | 6.77 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Lys Met His | 6.81 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 4-Hydroxylevamisole Glucuronide | 7.31 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Prasterone sulfate | 7.38 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Lactacystin | 7.38 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Glu Glu Met | 7.38 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Mesuagin | 7.39 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 5?-Androstan-3?-ol-17-one sulfate - 7.5459185 | 7.55 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acid | 7.6 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Allopregnanalone sulfate | 7.6 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 5?-Androstan-3?-ol-17-one sulfate - 7.7291727 | 7.73 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | His Cys His | 7.73 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Marinobufagenin | 7.76 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Tauroursodeoxycholic acid | 7.92 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Prasterone sulfate - 7.9986095 | 8 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 5?-Androstan-3?-ol-17-one sulfate - 8.185043 | 8.19 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 2-Hydroxy-3-(4-methoxyethylphenoxy)-propanoic acid | 8.22 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | pregnenolone sulfate | 8.24 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Hydroxyibuprofen | 8.61 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Deoxycholic acid glycine conjugate | 9.09 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Trp His Glu | 9.14 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 6-dehydrotestosterone 17-glucosiduronic acid | 9.14 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Herbimycin | 10.24 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | MID42238:(6R)-1?,25-dihydroxyvitamin D3 6,19-sulfur dioxide adduct / (6R)-1?,25-dihydroxycholecalcif | 10.51 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Z-Arg-Arg-NHMec | 11.05 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid | 11.2 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 11E-octadecen-9-ynoic acid | 12.66 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 11-methyl-tridecanoic acid | 12.84 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 6E,9E-octadecadienoic acid | 13.05 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | Trilauroyl-glycerol | 13.05 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 36:4(21Z,24Z,27Z,30Z) | 13.45 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 6-Gingerol | 13.49 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood | |
| AN000869 | 13Z-octadecenoic acid | 13.5 | Minutes | ST000566 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Blood |
